DANIELA CARLA DE SOUZA

(Fonte: Lattes)
Índice h a partir de 2011
10
Projetos de Pesquisa
Unidades Organizacionais
PAINT-62, Hospital Universitário

Resultados de Busca

Agora exibindo 1 - 7 de 7
  • article 13 Citação(ões) na Scopus
    Operationalizing Appropriate Sepsis Definitions in Children Worldwide: Considerations for the Pediatric Sepsis Definition Taskforce
    (2023) CARROL, Enitan D.; RANJIT, Suchitra; MENON, Kusum D.; BENNETT, Tellen D.; SANCHEZ-PINTO, L. Nelson J.; ZIMMERMAN, Jerry J. C.; SOUZA, Daniela C. R.; SORCE, Lauren R. G.; RANDOLPH, Adrienne G.; ISHIMINE, Paul; OLIVEIRA, Claudio Flauzino de; LODHA, Rakesh; HARMON, Lori; WATSON, R. Scott J.; SCHLAPBACH, Luregn J.; KISSOON, Niranjan C.; ARGENT, Andrew C.
    Sepsis is a leading cause of global mortality in children, yet definitions for pediatric sepsis are outdated and lack global applicability and validity. In adults, the Sepsis-3 Definition Taskforce queried databases from high-income countries to develop and validate the criteria. The merit of this definition has been widely acknowledged; however, important considerations about less-resourced and more diverse settings pose challenges to its use globally. To improve applicability and relevance globally, the Pediatric Sepsis Definition Taskforce sought to develop a conceptual framework and rationale of the critical aspects and context-specific factors that must be considered for the optimal operationalization of future pediatric sepsis definitions. It is important to address challenges in developing a set of pediatric sepsis criteria which capture manifestations of illnesses with vastly different etiologies and underlying mechanisms. Ideal criteria need to be unambiguous, and capable of adapting to the different contexts in which children with suspected infections are present around the globe. Additionally, criteria need to facilitate early recognition and timely escalation of treatment to prevent progression and limit life-threatening organ dysfunction. To address these challenges, locally adaptable solutions are required, which permit individualized care based on available resources and the pretest probability of sepsis. This should facilitate affordable diagnostics which support risk stratification and prediction of likely treatment responses, and solutions for locally relevant outcome measures. For this purpose, global collaborative databases need to be established, using minimum variable datasets from routinely collected data. In summary, a ""Think globally, act locally"" approach is required.
  • article 0 Citação(ões) na Scopus
    Avoid re-interpreting fluid bolus recommendations for low-income settings
    (2023) RANJIT, Suchitra; KISSOON, Niranjan; ARGENT, Andrew; INWALD, David; VENTURA, Andrea Maria Cordeiro; JABORINSKY, Roberto; SANKAR, Jhuma; SOUZA, Daniela Carla de; NATRAJ, Rajeswari; OLIVEIRA, Claudio Flauzino De; SAMRANSAMRUAJKIT, Rujipat; JAYASHREE, Muralidharan; SCHLAPBACH, Luregn J.
  • article 6 Citação(ões) na Scopus
    Haemodynamic support for paediatric septic shock: a global perspective
    (2023) RANJIT, Suchitra; KISSOON, Niranjan; ARGENT, Andrew; INWALD, David; VENTURA, Andrea Maria Cordeiro; JABORINSKY, Roberto; SANKAR, Jhuma; SOUZA, Daniela Carla de; NATRAJ, Rajeswari; OLIVEIRA, Claudio Flauzino De; SAMRANSAMRUAJKIT, Rujipat; JAYASHREE, Muralidharan; SCHLAPBACH, Luregn J.
    Septic shock is a leading cause of hospitalisation, morbidity, and mortality for children worldwide. In 2020, the paediatric Surviving Sepsis Campaign (SSC) issued evidence-based recommendations for clinicians caring for children with septic shock and sepsis-associated organ dysfunction based on the evidence available at the time. There are now more trials from multiple settings, including low-income and middle-income countries (LMICs), addressing optimal fluid choice and amount, selection and timing of vasoactive infusions, and optimal monitoring and therapeutic endpoints. In response to developments in adult critical care to trial personalised haemodynamic management algorithms, it is timely to critically reassess the current state of applying SSC guidelines in LMIC settings. In this Viewpoint, we briefly outline the challenges to improve sepsis care in LMICs and then discuss three key concepts that are relevant to management of children with septic shock around the world, especially in LMICs. These concepts include uncertainties surrounding the early recognition of paediatric septic shock, choices for initial haemodynamic support, and titration of ongoing resuscitation to therapeutic endpoints. Specifically, given the evolving understanding of clinical phenotypes, we focus on the controversies surrounding the concepts of early fluid resuscitation and vasoactive agent use, including insights gained from experience in LMICs and high-income countries. We outline the key components of sepsis management that are both globally relevant and translatable to low-resource settings, with a view to open the conversation to the large variety of treatment pathways, especially in LMICs. We emphasise the role of simple and easily available monitoring tools to apply the SSC guidelines and to tailor individualised support to the patient's cardiovascular physiology.
  • article 21 Citação(ões) na Scopus
    The Current and Future State of Pediatric Sepsis Definitions: An International Survey
    (2022) MORIN, Luc; HALL, Mark; SOUZA, Daniela de; Lu Guoping; JABORNISKY, Roberto; SHIME, Nobuaki; RANJIT, Suchitra; GILHOLM, Patricia; NAKAGAWA, Satoshi; ZIMMERMAN, Jerry J.; SORCE, Lauren R.; ARGENT, Andrew; KISSOON, Niranjan; TISSIERES, Pierre; WATSON, R. Scott; SCHLAPBACH, Luregn J.
    BACKGROUND AND OBJECTIVES: Definitions for pediatric sepsis were established in 2005 without data-driven criteria. It is unknown whether the more recent adult Sepsis-3 definitions meet the needs of providers caring for children. We aimed to explore the use and applicability of criteria to diagnose sepsis and septic shock in children across the world. METHODS: This is an international electronic survey of clinicians distributed across international and national societies representing pediatric intensive care, emergency medicine, pediatrics, and pediatric infectious diseases. Respondents stated their preferences on a 5-point Likert scale. RESULTS: There were 2835 survey responses analyzed, of which 48% originated from upper-middle income countries, followed by high income countries (38%) and low or lower-middle income countries (14%). Abnormal vital signs, laboratory evidence of inflammation, and microbiologic diagnoses were the criteria most used for the diagnosis of ""sepsis."" The 2005 consensus definitions were perceived to be the most useful for sepsis recognition, while Sepsis-3 definitions were stated as more useful for benchmarking, disease classification, enrollment into trials, and prognostication. The World Health Organization definitions were perceived as least useful across all domains. Seventy one percent of respondents agreed that the term sepsis should be restricted to children with infection-associated organ dysfunction. CONCLUSIONS: Clinicians around the world apply a myriad of signs, symptoms, laboratory studies, and treatment factors when diagnosing sepsis. The concept of sepsis as infection with associated organ dysfunction is broadly supported. Currently available sepsis definitions fall short of the perceived needs. Future diagnostic algorithms should be pragmatic and sensitive to the clinical settings.
  • article 50 Citação(ões) na Scopus
    Criteria for Pediatric Sepsis-A Systematic Review and Meta-Analysis by the Pediatric Sepsis Definition Taskforce*
    (2022) MENON, Kusum; SCHLAPBACH, Luregn J.; AKECH, Samuel; ARGENT, Andrew; BIBAN, Paolo; CARROL, Enitan D.; CHIOTOS, Kathleen; CHISTI, Mohammod Jobayer; EVANS, Idris V. R.; INWALD, David P.; ISHIMINE, Paul; KISSOON, Niranjan; LODHA, Rakesh; NADEL, Simon; OLIVEIRA, Claudio Flauzino; PETERS, Mark; SADEGHIRAD, Benham; SCOTT, Halden F.; SOUZA, Daniela C. de; TISSIERES, Pierre; WATSON, R. Scott; WIENS, Matthew O.; WYNN, James L.; ZIMMERMAN, Jerry J.; SORCE, Lauren R.
    Objective: To determine the associations of demographic, clinical, laboratory, organ dysfunction, and illness severity variable values with: 1) sepsis, severe sepsis, or septic shock in children with infection and 2) multiple organ dysfunction or death in children with sepsis, severe sepsis, or septic shock. Data Sources: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched from January 1, 2004, and November 16, 2020. Study Selection: Case-control studies, cohort studies, and randomized controlled trials in children greater than or equal to 37-week-old postconception to 18 years with suspected or confirmed infection, which included the terms ""sepsis,"" ""septicemia,"" or ""septic shock"" in the title or abstract. Data Extraction: Study characteristics, patient demographics, clinical signs or interventions, laboratory values, organ dysfunction measures, and illness severity scores were extracted from eligible articles. Random-effects meta-analysis was performed. Data Synthesis: One hundred and six studies met eligibility criteria of which 81 were included in the meta-analysis. Sixteen studies (9,629 patients) provided data for the sepsis, severe sepsis, or septic shock outcome and 71 studies (154,674 patients) for the mortality outcome. In children with infection, decreased level of consciousness and higher Pediatric Risk of Mortality scores were associated with sepsis/severe sepsis. In children with sepsis/severe sepsis/septic shock, chronic conditions, oncologic diagnosis, use of vasoactive/inotropic agents, mechanical ventilation, serum lactate, platelet count, fibrinogen, procalcitonin, multi-organ dysfunction syndrome, Pediatric Logistic Organ Dysfunction score, Pediatric Index of Mortality-3, and Pediatric Risk of Mortality score each demonstrated significant and consistent associations with mortality. Pooled mortality rates varied among high-, upper middle-, and lower middle-income countries for patients with sepsis, severe sepsis, and septic shock (p < 0.0001). Conclusions: Strong associations of several markers of organ dysfunction with the outcomes of interest among infected and septic children support their inclusion in the data validation phase of the Pediatric Sepsis Definition Taskforce.
  • article 9 Citação(ões) na Scopus
    Challenges of implementing the Paediatric Surviving Sepsis Campaign International Guidelines 2020 in resource-limited settings: A real-world view beyond the academia
    (2021) WOOLDRIDGE, G.; O’BRIEN, N.; MUTTALIB, F.; ABBAS, Q.; APPIAH, J. A.; BAKER, T.; BANSAL, A.; BASNET, S.; CAMPOS-MIñO, S.; SOUZA, D. C. de; DíAZ, F.; DRAMOWSKI, A.; FERNáNDEZ-SARMIENTO, J.; FUSTIñANA, A.; GONZáLEZ, G.; JABORNISKY, R.; JARAMILLO-BUSTAMANTE, J. C.; KEE, C. Y. K. Y.; LANG, H.-J.; LANZIOTTI, V. S.; LONCARICA, G. K.; MOHSENIBOD, H.; ODE, B.; MURTHY, S.; ARNIM, A. V. S. A.-V.; HANSMANN, A.; GONZáLEZ-DAMBRAUSKAS, S.
    The Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-associated Organ Dysfunction in Children was released in 2020 and is intended for use in all global settings that care for children with sepsis. However, practitioners managing children with sepsis in resource-limited settings (RLS) face several challenges and disease patterns not experienced by those in resource-rich settings. Based upon our collective experience from RLS, we aimed to reflect on the difficulties of implementing the international guidelines. We believe there is an urgent need for more evidence from RLS on feasible, efficacious approaches to the management of sepsis and septic shock that could be included in future context-specific guidelines. © 2021, Sociedad Chilena de Pediatria. All rights reserved.
  • article 57 Citação(ões) na Scopus
    COVID-19 PICU guidelines: for high- and limited-resource settings
    (2020) KACHE, Saraswati; CHISTI, Mohammod Jobayer; GUMBO, Felicity; MUPERE, Ezekiel; ZHI, Xia; NALLASAMY, Karthi; NAKAGAWA, Satoshi; LEE, Jan Hau; NARDO, Matteo Di; OLIVA, Pedro de la; KATYAL, Chhavi; ANAND, Kanwaljeet J. S.; SOUZA, Daniela Carla de; LANZIOTTI, Vanessa Soares; CARCILLO, Joseph
    Background Fewer children than adults have been affected by the COVID-19 pandemic, and the clinical manifestations are distinct from those of adults. Some children particularly those with acute or chronic co-morbidities are likely to develop critical illness. Recently, a multisystem inflammatory syndrome (MIS-C) has been described in children with some of these patients requiring care in the pediatric ICU. Methods An international collaboration was formed to review the available evidence and develop evidence-based guidelines for the care of critically ill children with SARS-CoV-2 infection. Where the evidence was lacking, those gaps were replaced with consensus-based guidelines. Results This process has generated 44 recommendations related to pediatric COVID-19 patients presenting with respiratory distress or failure, sepsis or septic shock, cardiopulmonary arrest, MIS-C, those requiring adjuvant therapies, or ECMO. Evidence to explain the milder disease patterns in children and the potential to use repurposed anti-viral drugs, anti-inflammatory or anti-thrombotic therapies are also described. Conclusion Brief summaries of pediatric SARS-CoV-2 infection in different regions of the world are included since few registries are capturing this data globally. These guidelines seek to harmonize the standards and strategies for intensive care that critically ill children with COVID-19 receive across the world. Impact At the time of publication, this is the latest evidence for managing critically ill children infected with SARS-CoV-2. Referring to these guidelines can decrease the morbidity and potentially the mortality of children effected by COVID-19 and its sequalae. These guidelines can be adapted to both high- and limited-resource settings.